Intracerebral clysis in a rat glioma model

Neurosurgery

Volumn 46, Issue 3, 2000, Pages 683-691

  Bruce, Jeffrey N ^a   Falavigna, Asdrubal ^a   Johnson, Jeffrey P ^a   Hall, Jonathan S ^a   Birch, Barry D ^a   Yoon, Jung T ^a   Wu, Edward X ^b   Fine, Robert L ^c   Parsa, Andrew T ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Blood brain barrier; Brain neoplasm; Convection enhanced microinfusion; Drug delivery; Glioma; Interstitial therapy; Intracerebral clysis

Indexed keywords

ALBUMIN; CARMUSTINE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FRONTAL LOBE; GLIOMA; INFUSION SYSTEM; INTRACEREBRAL CLYSIS; INTRACRANIAL PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TECHNIQUE; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

EID: 0034016827     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200003000-00031     Document Type: Article

References (56)

1. Ananth CV, Kleinbaum DG: Regression models for ordinal responses: A review of methods and applications. Int J Epidemiol 26:1323-1333, 1997.
2. Andrews BT, Levy M, McIntosh TK, Pitts LH: An epidural intracranial pressure monitor for experimental use in the rat. Neurol Res 10:123-126, 1988.
3. Badie B, Goh CS, Klaver J, Herweijer H, Boothman DA: Combined radiation and p53 gene therapy of malignant glioma cells. Cancer Gene Ther 6:155-162, 1999.
4. Badie B, Hunt K, Economou JS, Black KL: Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery 35:910-916, 1994.
5. Badie B, Kramar MH, Lau R, Boothman DA, Economou JS, Black KL: Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors. J Neurooncol 37:217-222, 1998.
6. Barker FG II: Analysis of the relationship between long-term operative success and a transient or delayed operative side effect. Neurosurgery 39:412-416, 1996.
7. Barker FG II, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42: 709-723, 1998.
8. Barth RF: Rat brain tumor models in experimental neuro-oncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36:91-102, 1998.
9. Barth KNM, Onesti ST, Krauss WE, Solomon RA: A simple and reliable technique to monitor intracranial pressure in the rat: Technical note. Neurosurgery 30:138-140, 1992.
10. Bartus RT, Elliott P, Hayward N, Dean R, McEwen EL, Fisher SK: Permeability of the blood brain barrier by the bradykinin agonist, RMP7: Evidence for a sensitive autoregulated receptor-mediated system. Immunopharmacology 33:270-278, 1996.
11. Berger MS, Tucker A, Spence A, Winn HR: Reoperation for glioma. Clin Neurosurg 39:172-186, 1992.
12. Bobo H, Kapp JP, Vance R: Effect of intra-arterial cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: Proposal of a new method of intra-arterial dosage calculation. J Neurooncol 13:291-299, 1992.
13. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91:2076-2080, 1994.
14. Brandes AA, Fiorentino MV: The role of chemotherapy in recurrent malignant gliomas: An overview. Cancer Invest 14:551-559, 1996.
15. Brem H, Ewend MG, Piantadosi S, Greenhoot J, Burger PC, Sisti M: The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial. J Neurooncol 26:111-123, 1995.
16. Brem H, Mahaley MS Jr, Vick NA, Black KL, Schold SC Jr, Burger PC, Friedman AH, Ciric IS, Eller TW, Cozzens JW, Kenealy JN: Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74:441-446, 1991.
17. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G, The Polymer Brain Tumor Treatment Group: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas: The Polymer Brain Tumor Treatment Group. Lancet 345:1008-1012, 1995.
18. Brem H, Tamargo RJ, Olivi A, Pinn M, Weingart JD, Wharam M, Epstein JI: Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. J Neurosurg 80:283-290, 1994.
19. Broaddus WC, Prabhu SS, Gillies GT, Neal J, Conrad WS, Chen ZJ, Fillmore H, Young HF: Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion. J Neurosurg 88: 734-742, 1998.
20. Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH: Variables affecting convection-enhanced delivery to the striatum: A systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 90:315-320, 1999.
21. Clayman DA, Wolpert SM, Heros DO: Superselective arterial BCNU infusion in the treatment of patients with malignant gliomas AJNR Am J Neuroradiol 10:767-771, 1989.
22. Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG Shapiro WR, Mealey J Jr, Ransohoff JD, Paoletti P, Smith KR, Odom GL, Hunt WE, Young B, Alexander E, Walker MD, Pistenmaa DA: Results of a randomized trial comparing BCNU plus radiotherapy streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 16:1389-1396, 1989.
23. Fetell MR, Housepian EM, Oster MW, Cote DN, Sisti MB, Marcus SG, Fischer PB: Intratumor administration of beta-interferon in recurrent malignant gliomas: A phase I clinical and laboratory study. Cancer 65:78-83, 1990.
24. Fung LK, Ewend MG, Sills A, Sipos EP, Thompson R, Watts M, Colvin OM, Brem H, Saltzman WM: Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res 58:672-684, 1998.
25. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992.
26. Geer CP, Grossman SA: Interstitial fluid flow along white matter tracts: A potentially important mechanism for the dissemination of primary brain tumors. J Neurooncol 32:193-201, 1997.
27. 14C-sucrose delivery to the brain by intravenous, intraventricular, and convection-enhanced intracerebral infusion. J Neurosurg 90:321-331, 1999.
28. Hess CF, Schaaf JC, Kortmann RD, Schabet M, Bamberg M: Malignant glioma: Patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 30:146-149, 1994.
29. Introzzi G, Paoletti P, Pezzotta S, Robustelli della Cuna G, Rodriguez y Baena R: The use of BCNU in chemotherapy of rumors of the central nervous system. J Neurosurg Sci 19:223-225, 1975.
30. Iwadate Y, Namba H, Saegusa T, Sueyoshi K: Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors. J Neurooncol 15:185-193, 1993.
31. Jain RK: Transport of molecules in the tumor interstitium: A review. Cancer Res 47:3039-3051, 1987.
32. Jain RK: Delivery of novel therapeutic agents in tumors: Physiologic barriers and strategies. J Natl Cancer Inst 81:570-576, 1989.
33. Jain RK: Barriers to drug delivery in solid tumors. Sci Am 271: 58-65, 1994.
34. Kaiser MG, Parsa AT, Yoon JT, Blair G, Hall J, Bruce JN: Intracerebral clysis enhances the distribution of adenoviral transfection in the rat brain. Presented at the 48th Annual Meeting of the Congress of Neurological Surgeons, Seattle, Washington, October 3-8, 1998.
35. Kimler BF, Liu C, Evans RG, Morantz RA: Intracerebral chemotherapy in the 9L rat brain tumor model. J Neurooncol 14:191-200, 1992.
36. Kroll RA, Pagel MA, Muldoon LL, Roman-Goldstein S, Neuwelt EA: Increasing volume of distribution to the brain with interstitial infusion: Dose, rather than convection, might be the most important factor. Neurosurgery 38:746-754, 1996.
37. Laske DW, Morrison PF, Lieberman DM, Corthesy ME, Reynolds JC, Stewart-Henney PA, Koong SS, Cummins A, Paik CH, Oldfield EH: Chronic interstitial infusion of protein to primate brain: Determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg 87:586-594, 1997.
38. Laske DW, Youle RJ, Oldfield EH: Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3:1362-1368, 1997.
39. Laurent TC, Preston BN, Pertoft H, Gustafsson B, McCabe M: Diffusion of linear polymers in hyaluronate solutions. Eur J Biochem 53:129-136, 1975.
40. Lieberman DM, Laske DW, Morrison PF, Bankiewicz KS, Oldfield EH: Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg 82:1021-1029, 1995.
41. Loeffler JS, Alexander ED, Hochberg FH, Wen PY, Morris JH, Schoene WC, Siddon RL, Morse RH, Black PM: Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 19:1455-1462, 1990.
42. Lonser RR, Gogate N, Morrison PF, Wood JD, Oldfield EH: Direct convective delivery of macromolecules to the spinal cord. J Neurosurg 89:616-622, 1998.
43. Lonser RR, Weil RJ, Morrison PF, Governale LS, Oldfield EH: Direct convective delivery of macromolecules to peripheral nerves. J Neurosurg 89:610-615, 1998.
44. Mize RR: Quantitative image analysis for immunocytochemistry and in situ hybridization. J Neurosci Methods 54:219-237, 1994.
45. Morreale VM, Herman BH, Der-Minassian V, Palkovits M, Klubes P, Perry D, Csiffary A, Lee AP: A brain-tumor model utilizing stereotactic implantation of a permanent cannula. J Neurosurg 78:959-965, 1993.
46. Morrison PF, Laske DW, Bobo H, Oldfield EH, Dedrick RL: High-flow microinfusion: Tissue penetration and pharmacodynamics. Am J Physiol 266:R292-R305, 1994.
47. Nugent LJ, Jain RK: Pore and fiber matrix models for diffusive transport in normal and neoplastic tissues. Microvasc Res 28:270-274, 1984.
48. Ohata K, Marmarou A: Clearance of brain edema and macromolecules through the cortical extracellular space. J Neurosurg 77: 387-396, 1992.
49. Prabhu SS, Broaddus WC, Gillies GT, Loudon WG, Chen Z, Smith B: Distribution of macromolecular dyes in brain using positive pressure infusion: A model for direct controlled delivery of therapeutic agents. Surg Neurol 50:367-375, 1998.
50. Rajan B, Ross G, Lim CC, Ashley S, Goode D, Traish D, Brada M: Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy. Eur J Cancer 12:1809-1815, 1994.
51. 131I: Comparison of the results obtained in recurrent and newly diagnosed tumors. Cancer Res 55(Suppl):5952s-5956s, 1995.
52. Schroder U, Arfors KE, Tangen O: Stability of fluorescein labeled dextrans in vivo and in vitro. Microvasc Res 11:33-39, 1976.
53. Silbergeld DL, Chicoine MR: Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 86:525-531, 1997.
54. Tator CH: Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy. Surg Neurol 7:73-77, 1977.
55. Tomita T: Interstitial chemotherapy for brain tumors: Review. J Neurooncol 10:57-74, 1991.
56. Zirzow GC, Sanchez OA, Murray GJ, Brady RO, Oldfield EH: Delivery, distribution, and neuronal uptake of exogenous mannose-terminal glucocerebrosidase in the intact rat brain. Neurochem Res 24:301-305, 1999.